St. Joseph, MO, United States of America

David E Gorcyca

USPTO Granted Patents = 18 


 

Average Co-Inventor Count = 4.4

ph-index = 15

Forward Citations = 449(Granted Patents)


Company Filing History:


Years Active: 1995-2014

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: David E. Gorcyca - Innovator in Veterinary Vaccines

Introduction

David E. Gorcyca, an accomplished inventor based in St. Joseph, Missouri, has made significant contributions to the field of veterinary medicine. With a strong portfolio of 18 patents, his work primarily focuses on the development of effective vaccines for porcine diseases.

Latest Patents

One of his latest innovations is a vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) based on isolate JA-142. This invention involves substantially avirulent forms of atypical PRRS virus obtained through cell culture passaging of virulent forms of the virus. This vaccine effectively elicits a PRRS specific antibody response in host animals, providing immunity against both traditional and newly isolated atypical strains of the PRRS virus. His preferred passaging technique ensures that the virus remains in a logarithmic growth phase throughout the process, thereby minimizing the time required for attenuation. Additionally, this invention includes diagnostic testing methods to distinguish between animals infected with field strains and those with attenuated strains of PRRS virus (PRRSV).

Career Highlights

Throughout his career, David has collaborated with prominent institutions and organizations, most notably Boehringer Ingelheim Vetmedica GmbH and South Dakota State University. His innovative contributions have garnered recognition within the scientific community.

Collaborations

David E. Gorcyca has worked alongside respected colleagues such as Danny W. Chladek and Louis L. Harris. These collaborations have further enhanced his research and development efforts, paving the way for advancements in the field of veterinary immunology.

Conclusion

David E. Gorcyca continues to be a key figure in the innovation of veterinary vaccines. His work not only addresses current challenges in porcine health but also lays the groundwork for future discoveries in veterinary medicine. With his extensive patent portfolio and dedication to research, Gorcyca's impact on the industry is both profound and enduring.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…